Literature DB >> 34797521

Carbon Monoxide-Neuroglobin Axis Targeting Metabolism Against Inflammation in BV-2 Microglial Cells.

Daniela Dias-Pedroso1, José S Ramalho1, Vilma A Sardão2, John G Jones2, Carlos C Romão3, Paulo J Oliveira2, Helena L A Vieira4,5,6.   

Abstract

Microglia are the immune competent cell of the central nervous system (CNS), promoting brain homeostasis and regulating inflammatory response against infection and injury. Chronic or exacerbated neuroinflammation is a cause of damage in several brain pathologies. Endogenous carbon monoxide (CO), produced from the degradation of heme, is described as anti-apoptotic and anti-inflammatory in several contexts, including in the CNS. Neuroglobin (Ngb) is a haemoglobin-homologous protein, which upregulation triggers antioxidant defence and prevents neuronal apoptosis. Thus, we hypothesised a crosstalk between CO and Ngb, in particular, that the anti-neuroinflammatory role of CO in microglia depends on Ngb. A novel CO-releasing molecule (ALF826) based on molybdenum was used for delivering CO in microglial culture.BV-2 mouse microglial cell line was challenged with lipopolysaccharide (LPS) for triggering inflammation, and after 6 h ALF826 was added. CO exposure limited inflammation by decreasing inducible nitric oxide synthase (iNOS) expression and the production of nitric oxide (NO) and tumour necrosis factor-α (TNF-α), and by increasing interleukine-10 (IL-10) release. CO-induced Ngb upregulation correlated in time with CO's anti-inflammatory effect. Moreover, knocking down Ngb reversed the anti-inflammatory effect of CO, suggesting that dependents on Ngb expression. CO-induced Ngb upregulation was independent on ROS signalling, but partially dependent on the transcriptional factor SP1. Finally, microglial cell metabolism is also involved in the inflammatory response. In fact, LPS treatment decreased oxygen consumption in microglia, indicating a switch to glycolysis, which is associated with a proinflammatory. While CO treatment increased oxygen consumption, reverting LPS effect and indicating a metabolic shift into a more oxidative metabolism. Moreover, in the absence of Ngb, this phenotype was no longer observed, indicating Ngb is needed for CO's modulation of microglial metabolism. Finally, the metabolic shift induced by CO did not depend on alteration of mitochondrial population. In conclusion, neuroglobin emerges for the first time as a key player for CO signalling against exacerbated inflammation in microglia.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Carbon monoxide; Cell metabolism; Microglia; Neuroglobin; Neuroinflammation; Oxidative phosphorylation

Mesh:

Substances:

Year:  2021        PMID: 34797521     DOI: 10.1007/s12035-021-02630-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  65 in total

1.  Targeting the CD80/CD86 costimulatory pathway with CTLA4-Ig directs microglia toward a repair phenotype and promotes axonal outgrowth.

Authors:  Antoine Louveau; Véronique Nerrière-Daguin; Bernard Vanhove; Philippe Naveilhan; Michel Neunlist; Arnaud Nicot; Hélène Boudin
Journal:  Glia       Date:  2015-07-27       Impact factor: 7.452

Review 2.  Resolution of neuroinflammation: mechanisms and potential therapeutic option.

Authors:  Nikolaos Dokalis; Marco Prinz
Journal:  Semin Immunopathol       Date:  2019-11-08       Impact factor: 9.623

3.  Lipopolysaccharide-induced alteration of mitochondrial morphology induces a metabolic shift in microglia modulating the inflammatory response in vitro and in vivo.

Authors:  Syam Nair; Kristina S Sobotka; Pooja Joshi; Pierre Gressens; Bobbi Fleiss; Claire Thornton; Carina Mallard; Henrik Hagberg
Journal:  Glia       Date:  2019-01-13       Impact factor: 7.452

Review 4.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

5.  Glucose pathways adaptation supports acquisition of activated microglia phenotype.

Authors:  J Gimeno-Bayón; A López-López; M J Rodríguez; N Mahy
Journal:  J Neurosci Res       Date:  2014-02-07       Impact factor: 4.164

6.  Inflammatory response of microglial BV-2 cells includes a glycolytic shift and is modulated by mitochondrial glucose-regulated protein 75/mortalin.

Authors:  Ludmila A Voloboueva; John F Emery; Xiaoyun Sun; Rona G Giffard
Journal:  FEBS Lett       Date:  2013-02-08       Impact factor: 4.124

Review 7.  Pathophysiology of cerebral ischemia and brain trauma: similarities and differences.

Authors:  Helen M Bramlett; W Dalton Dietrich
Journal:  J Cereb Blood Flow Metab       Date:  2004-02       Impact factor: 6.200

8.  Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP.

Authors:  Yiguo Shen; David Kapfhamer; Angela M Minnella; Ji-Eun Kim; Seok Joon Won; Yanting Chen; Yong Huang; Ley Hian Low; Stephen M Massa; Raymond A Swanson
Journal:  Nat Commun       Date:  2017-09-22       Impact factor: 14.919

9.  Increased expression and altered subcellular distribution of cathepsin B in microglia induce cognitive impairment through oxidative stress and inflammatory response in mice.

Authors:  Junjun Ni; Zhou Wu; Veronika Stoka; Jie Meng; Yoshinori Hayashi; Christoph Peters; Hong Qing; Vito Turk; Hiroshi Nakanishi
Journal:  Aging Cell       Date:  2018-12-21       Impact factor: 9.304

Review 10.  Inflammasome activation and regulation: toward a better understanding of complex mechanisms.

Authors:  Danping Zheng; Timur Liwinski; Eran Elinav
Journal:  Cell Discov       Date:  2020-06-09       Impact factor: 10.849

View more
  1 in total

1.  Proteomic analysis and identification reveal the anti-inflammatory mechanism of clofazimine on lipopolysaccharide-induced acute lung injury in mice.

Authors:  Bo Yang; Zhan Gao; Qi-Shuang Li; Xiang-Ye Zhang; Lan Song; Yi-Ni Wang; Xin-Yue Wang; Lin-Lin Ji; Hong-Liang Xu; Hui Xie; Fu-Kai Feng; Xiao-Ping Li; Wei Li; Rong Wang; Guang-Shun Wang
Journal:  Inflamm Res       Date:  2022-08-13       Impact factor: 6.986

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.